Antonio Pares - Grifols SA Director of Planning and Control
| GIKLY Stock | USD 4.40 0.18 3.93% |
Director
Antonio Pares is Director of Planning and Control of Grifols SA ADR since 2014.
| Tenure | 10 years |
| Phone | 34 93 571 02 21 |
| Web | https://www.grifols.com |
Grifols SA Management Efficiency
The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0182 %, meaning that it generated $0.0182 on every $100 dollars invested by stockholders. Grifols SA's management efficiency ratios could be used to measure how well Grifols SA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Genevieve Berger | AstraZeneca PLC ADR | 64 | |
| Bonnie Bassler | Sanofi ADR | N/A | |
| Uwe Bicker | Sanofi ADR | 69 | |
| Jesse Goodman | GlaxoSmithKline PLC ADR | 69 | |
| Ann Cairns | AstraZeneca PLC ADR | 57 | |
| Suet Lee | Sanofi ADR | 60 | |
| JeanPhilippe Courtois | AstraZeneca PLC ADR | 54 | |
| Steven Mayer | Grifols SA ADR | 56 | |
| Susan Hockfield | Pfizer Inc | 70 | |
| Michel Demare | AstraZeneca PLC ADR | 62 | |
| James Quincey | Pfizer Inc | 56 | |
| Dimitri Azar | Novartis AG ADR | 59 | |
| Klaus Pohle | Sanofi ADR | 76 | |
| Tony Mok | AstraZeneca PLC ADR | N/A | |
| Frans Houten | Novartis AG ADR | 61 | |
| Graham Chipchase | AstraZeneca PLC ADR | 54 | |
| Simon Dingemans | GlaxoSmithKline PLC ADR | 53 | |
| James Kilts | Pfizer Inc | 71 | |
| Jose Gras | Grifols SA ADR | N/A | |
| Igor Landau | Sanofi ADR | 70 | |
| Deryck Maughan | GlaxoSmithKline PLC ADR | 66 | |
Management Performance
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0155 |
Grifols SA ADR Leadership Team
Elected by the shareholders, the Grifols SA's board of directors comprises two types of representatives: Grifols SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grifols. The board's role is to monitor Grifols SA's management team and ensure that shareholders' interests are well served. Grifols SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grifols SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Antonio Pares, Director of Planning and Control | ||
| Peter Allen, Chairman of Hospital OPS Division | ||
| Carsten Schroeder, President Of The Diagnostic Division | ||
| Albert Roura, CEO of Laboratorios Grifols SA | ||
| Jose Garcia, Director General De Laboratorios Grifols | ||
| Lafmin Morgan, President Of The Bioscience And Hospital Division | ||
| Juan Roura, Vice President of Production, Executive Director | ||
| Eva Tubau, Chief Scientific Officer | ||
| Anna Lluch, Independent Director | ||
| Carlos Fernandez, Deputy Industrial Vice President | ||
| Jose Gras, Director, Representative of Thorthol Holdings BV | ||
| Maria Llano, Chief Officer | ||
| Edgar Jannotta, Independent Director | ||
| Vicente Torre, CTO | ||
| Mateo Humbert, Director of Human Resources | ||
| Montserrat Calvo, Chief Administrative Officer, Controller | ||
| Montserrat Llamas, Chief Officer | ||
| Ramon Roca, Vice-President of Marketing and Sales and Executive Director | ||
| Vctor Deu, CoCEO Director | ||
| David Bell, Vice President of Corporate Operations and Development of Grifols Inc and United States Subsidiaries | ||
| Victor Deu, Executive Director | ||
| Luis Bobadilla, Independent Director | ||
| Inigo Mardones, Director | ||
| Thomas Glanzmann, Director | ||
| Carina Lazaro, Independent Director | ||
| Joel Abelson, President of North America Commercial Division of Grifols Inc | ||
| Steven Mayer, Director | ||
| Jose Fulla, CEO of Diagnostic Industrial Group | ||
| Javier Ribes, CEO of Instituto Grifols SA | ||
| Alfredo Guerra, CFO and Corporate VP | ||
| Raimon Roura, Non-Member Secretary of the Board | ||
| Miguel Montblanch, Chariman of Global Operations Network | ||
| Victor Roura, Chairman, CEO and President and Member of Appointments and Remuneration Committee | ||
| Brett Ingersoll, Director | ||
| Shinji Wada, President of Plasma Centers of Grifols Inc | ||
| Tomas Gelabert, Director | ||
| Nuria Lapea, Risk Treasury | ||
| M Tubau, Co Affairs | ||
| Steven JD, Ex Chairman | ||
| Marla Salmon, Independent Director | ||
| Nuria Barnes, Non-Member Assistant Secretary of the Board | ||
| Gregory Rich, President of Grifols Inc and Subsidiaries in the US | ||
| Belen Morenes, Independent Director | ||
| Nuria Lapena, Director of Shareholder and Investor Relations |
Grifols Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Grifols SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 16.07 B | |||
| Shares Outstanding | 1.36 B | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | 9.31 X | |||
| Price To Book | 1.03 X | |||
| Price To Sales | 1.47 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grifols SA ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Grifols Pink Sheet analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |